372 related articles for article (PubMed ID: 31056304)
1. Evaluating Benefit-risk Decision-making in Spinal Muscular Atrophy: A First-ever Study to Assess Risk Tolerance in the SMA Patient Community.
Cruz R; Belter L; Wasnock M; Nazarelli A; Jarecki J
Clin Ther; 2019 May; 41(5):943-960.e4. PubMed ID: 31056304
[TBL] [Abstract][Full Text] [Related]
2. Perspectives on Spinraza (Nusinersen) Treatment Study: Views of Individuals and Parents of Children Diagnosed with Spinal Muscular Atrophy.
Pacione M; Siskind CE; Day JW; Tabor HK
J Neuromuscul Dis; 2019; 6(1):119-131. PubMed ID: 30594933
[TBL] [Abstract][Full Text] [Related]
3. "I have SMA, SMA doesn't have me": a qualitative snapshot into the challenges, successes, and quality of life of adolescents and young adults with SMA.
Mazzella A; Curry M; Belter L; Cruz R; Jarecki J
Orphanet J Rare Dis; 2021 Feb; 16(1):96. PubMed ID: 33618755
[TBL] [Abstract][Full Text] [Related]
4. Quality of life data for individuals affected by spinal muscular atrophy: a baseline dataset from the Cure SMA Community Update Survey.
Belter L; Cruz R; Jarecki J
Orphanet J Rare Dis; 2020 Aug; 15(1):217. PubMed ID: 32838797
[TBL] [Abstract][Full Text] [Related]
5. The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular Atrophy.
Belter L; Jarecki J; Reyna SP; Cruz R; Jones CC; Schroth M; O'Toole CM; O'Brien S; Hall SA; Johnson NB; Paradis AD
J Neuromuscul Dis; 2021; 8(1):109-123. PubMed ID: 33104036
[TBL] [Abstract][Full Text] [Related]
6. Understanding European patient expectations towards current therapeutic development in spinal muscular atrophy.
Gusset N; Stalens C; Stumpe E; Klouvi L; Mejat A; Ouillade MC; de Lemus M
Neuromuscul Disord; 2021 May; 31(5):419-430. PubMed ID: 33752935
[TBL] [Abstract][Full Text] [Related]
7. Burden of Spinal Muscular Atrophy (SMA) on Patients and Caregivers in Canada.
McMillan HJ; Gerber B; Cowling T; Khuu W; Mayer M; Wu JW; Maturi B; Klein-Panneton K; Cabalteja C; Lochmüller H
J Neuromuscul Dis; 2021; 8(4):553-568. PubMed ID: 33749617
[TBL] [Abstract][Full Text] [Related]
8. A qualitative study of perceptions of meaningful change in spinal muscular atrophy.
McGraw S; Qian Y; Henne J; Jarecki J; Hobby K; Yeh WS
BMC Neurol; 2017 Apr; 17(1):68. PubMed ID: 28376816
[TBL] [Abstract][Full Text] [Related]
9. "The Whole Game is Changing and You've Got Hope": Australian Perspectives on Treatment Decision Making in Spinal Muscular Atrophy.
Farrar MA; Carey KA; Paguinto SG; Kasparian NA; De Abreu Lourenço R
Patient; 2020 Aug; 13(4):389-400. PubMed ID: 32266662
[TBL] [Abstract][Full Text] [Related]
10. Quality of life of children with spinal muscular atrophy and their caregivers from the perspective of caregivers: a Chinese cross-sectional study.
Yao M; Ma Y; Qian R; Xia Y; Yuan C; Bai G; Mao S
Orphanet J Rare Dis; 2021 Jan; 16(1):7. PubMed ID: 33407670
[TBL] [Abstract][Full Text] [Related]
11. A community-engaged approach to quantifying caregiver preferences for the benefits and risks of emerging therapies for Duchenne muscular dystrophy.
Peay HL; Hollin I; Fischer R; Bridges JF
Clin Ther; 2014 May; 36(5):624-37. PubMed ID: 24852596
[TBL] [Abstract][Full Text] [Related]
12. Parents' Experiences of Information and Decision Making in the Care of Their Child With Severe Spinal Muscular Atrophy: A Population Survey.
Beernaert K; Lövgren M; Jeppesen J; Werlauff U; Rahbek J; Sejersen T; Kreicbergs U
J Child Neurol; 2019 Mar; 34(4):210-215. PubMed ID: 30642225
[TBL] [Abstract][Full Text] [Related]
13. Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment.
Monnette A; Chen E; Hong D; Bazzano A; Dixon S; Arnold WD; Shi L
Orphanet J Rare Dis; 2021 Jan; 16(1):36. PubMed ID: 33472673
[TBL] [Abstract][Full Text] [Related]
14. Spinal muscular atrophy: survival pattern and functional status.
Chung BH; Wong VC; Ip P
Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
[TBL] [Abstract][Full Text] [Related]
15. Essential competencies for physical therapist managing individuals with spinal muscular atrophy: A delphi study.
Timmerberg JF; Krosschell KJ; Dunaway Young S; Uher D; Yun C; Montes J
PLoS One; 2021; 16(4):e0249279. PubMed ID: 33886555
[TBL] [Abstract][Full Text] [Related]
16. The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices.
Peterson IS; Mazzella AJ; Belter LT; Curry MA; Cruz RE; Jarecki J
Neurol Ther; 2022 Sep; 11(3):1167-1181. PubMed ID: 35635603
[TBL] [Abstract][Full Text] [Related]
17. Patient-centered benefit-risk assessment in duchenne muscular dystrophy.
Hollin IL; Peay HL; Apkon SD; Bridges JFP
Muscle Nerve; 2017 May; 55(5):626-634. PubMed ID: 27649378
[TBL] [Abstract][Full Text] [Related]
18. Perceived Fatigue in Spinal Muscular Atrophy: A Pilot Study.
Dunaway Young S; Montes J; Kramer SS; Podwika B; Rao AK; De Vivo DC
J Neuromuscul Dis; 2019; 6(1):109-117. PubMed ID: 30562906
[TBL] [Abstract][Full Text] [Related]
19. Patient and Caregiver Treatment Preferences in Type 2 and Non-ambulatory Type 3 Spinal Muscular Atrophy: A Discrete Choice Experiment Survey in Five European Countries.
Lo SH; Lawrence C; Martí Y; Café A; Lloyd AJ
Pharmacoeconomics; 2022 Apr; 40(Suppl 1):103-115. PubMed ID: 34897574
[TBL] [Abstract][Full Text] [Related]
20. Parents as informal caregivers of children and adolescents with spinal muscular atrophy: a systematic review of quantitative and qualitative data on the psychosocial situation, caregiver burden, and family needs.
Brandt M; Johannsen L; Inhestern L; Bergelt C
Orphanet J Rare Dis; 2022 Jul; 17(1):274. PubMed ID: 35854387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
